# Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

> **NCT07519109** · PHASE1 · NOT_YET_RECRUITING · sponsor: **CSPC Ouyi Pharmaceutical Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** SYH9089 injection
- **DRUG:** Ropivacaine hydrochloride
- **DRUG:** 0.9 % sodium chloride

## Key facts

- **NCT ID:** NCT07519109
- **Lead sponsor:** CSPC Ouyi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07519109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07519109, "Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07519109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*